Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2006

View Archived Issues

PD-0325901 inhibits hepatocellular carcinoma growth in vivo

GW-427353 inhibits cholinergic contraction in human colon

ZK-156979 has therapeutic effect in experimental colitis

Spectrum presents Q1 highlights

Ono updates latest developments in pipeline

Milestones in Metabolex's diabetes and obesity collaboration with Astellas

Phase IIa trial studies Phosphagenics' transdermal morphine

Orally available calpain inhibitor provides in vivo neuroprotection against retinal ischemia

BioInvent considers protocol amendment for phase I/II study of BI-201 for HIV

Canadian notice of deficiency for GlucaGen

Shire disappointed at NICE's recommendation on patients with mild Alzheimer's

PEP-005 Topical studied for cutaneous squamous cell carcinoma in situ

Herceptin plus Arimidex prolongs PFS in advanced HER2 breast cancer

Sphingosine 1-phosphate S1P1 receptor agonists emerge from Merck R&D

Bristol-Myers Squibb presents antitumor activity of new VEGFR-2 inhibitor

Pfizer present new oral PDE5 inhibitor as a candidate for male erectile dysfunction

Recent patents describe new anticoagulants

Novel alpha 1a/1d adrenoreceptor antagonists claimed for BPH treatment

Agents with potential for the treatment of metabolic disorders described in recent patents

New report from Prous Science reviews treatment options for patients with muscular dystrophy

Oracea approved for rosacea

ISTA begins pivotal studies for once-daily Xibrom

Phase II study of LE-SN-38 in metastatic colorectal cancer begins enrollment

Ortec to file HDE for cryopreserved OrCel in epidermolysis bullosa

European approval for Zostavax

Astellas returns Japanese strontium ranelate rights to Servier

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...